"Limited Availability of Lilly's Mounjaro Dose in US Until Next Month"
TL;DR Summary
The U.S. FDA website indicates limited availability of Eli Lilly's diabetes drug Mounjaro's 12.5 milligram dose through February 2024 due to increased demand, with intermittent regional pharmacy stock outages possible. The drug, approved for type-2 diabetes and weight loss, contains tirzepatide and competes in a global market estimated to reach $100 billion by the end of the decade.
Topics:business#diabetes-drug#eli-lilly#fda#healthcare-pharmaceuticals#limited-availability#mounjaro
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
79%
272 → 58 words
Want the full story? Read the original article
Read on Reuters